The Chimeric Antigen Receptor (CAR)-T Cell Therapy market was valued at USD 2.72 Billion in 2024 and is expected to reach USD 6.65 Billion by 2032, growing at a CAGR of 11.8% (2024-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.